copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Cancer-Related Fatigue: Causes and Current Treatment Options This review aims to provide a summary on the current state of research on cancer-related fatigue (CRF) of survivors with local disease treated with curative intent We briefly summarize the prevalence, definition, evaluation, and etiology of CRF
Meeting Abstract: 2025 ASCO Annual Meeting I - ASCO Publications The iPRS was evaluated for association with CRF among women with non-metastatic breast cancer enrolled in one of two completed multi-site clinical trials of the University of Rochester Cancer Center NCI Community Oncology Research Program (NCORP) Research Base
Biological mechanisms of cancer-related fatigue in breast . . . CRF in BCS after finishing oncological treatment is a complex symptom for which a pathogenetic mechanism has not been identified Up to now most studies have focused on inflammation, but results are inconsistent
Coronary inflammation and cardiovascular risk in breast . . . This study confirmed that women with active breast cancer experience elevated risk for cardiac mortality, driven by high inflammation observed in all three coronary arteries before they receive any treatment
The diverse role of corticotropin-releasing factor (CRF) and . . . This review aims to present selected examples of the diverse and sometimes opposite effects of CRF and its receptor ligands in various pathophysiological states, including stress anxiety, depression, and processes associated with brain injury
Cancer-Related Fatigue: State of the Science - ScienceDirect Studies to elucidate the biologic expression profiles of CRF, to explicate the mechanisms through which particular interventions impact CRF, and to identify the mediators and moderators of fatigue outcomes will ultimately permit individually tailored approaches for the treatment of CRF